Relaxation Treatment for Anxiety in Adults Aged 60 or Older
BREATHE
Reducing Late-Life Anxiety and Improving Functioning With Self-Directed Relaxation
2 other identifiers
interventional
40
1 country
1
Brief Summary
The PI developed a self-directed program to treat late-life anxiety called Breathing, Relaxation, and Education for Anxiety Treatment in the Home Environment (BREATHE). This program consists of weekly video lessons that participants watch on digital video disc (DVD) along with weekly telephone check-ins. In BREATHE participants will learn two behavioral interventions: diaphragmatic breathing and progressive muscle relaxation (PMR). The purpose of the study is to examine whether the self-directed BREATHE program is superior to a wait list control in reducing anxiety in older adults with anxiety disorders. For those assigned to wait list control, they will be offered opportunity to participate in BREATHE treatment after 8 weeks of wait list.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2015
CompletedFirst Posted
Study publicly available on registry
April 29, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedResults Posted
Study results publicly available
January 27, 2020
CompletedJanuary 27, 2020
January 1, 2020
2.1 years
April 21, 2015
March 18, 2019
January 24, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Anxiety Symptoms
The Geriatric Anxiety Scale (GAS) is a 30-item measure of somatic, cognitive, and affective symptoms of anxiety. The first 25 items of the measure are used to compute the total score; the last 5 items provide information about the content of worries or fears. Total scores range from 0 to 75 with higher scores indicating worse anxiety. Participants provide severity ratings for items using on a four-point Likert-type scale.
Change from baseline to 8 weeks
Change in Activity Engagement
The Activity Card Sort contains 80 photographs that depict the performance of instrumental activities, low-physical-demand leisure activities, high-physical-demand leisure activities, and social activities. This measure will be used to assess engagement in activities. The score reported is the lifestyle-adjusted function score. It represents the percentage of activities ever completed that are perceived to be easy. Higher scores indicate greater ease of activity completion/engagement.
Change from baseline to 8 weeks
Secondary Outcomes (2)
Change in Depressive Symptoms
Change from baseline to 8 weeks
Change in Somatic Symptoms
Change from baseline to 8 weeks
Other Outcomes (2)
Change in Heart Rate
Change from baseline to 8 weeks
Change in Blood Pressure
Change from baseline to 8 weeks
Study Arms (2)
BREATHE
EXPERIMENTAL4 weeks DVD-delivered relaxation intervention program called breathe. The experimental intervention includes progressive muscle relaxation, diaphragmatic breathing, and home practice of the skills. Following the 4 weeks of treatment, participants will be asked to continue to practice at home for 4 weeks.
Wait List
NO INTERVENTION8 week wait list period. Participants assigned to wait list will have the opportunity to receive BREATHE arm after 8 weeks if interested.
Interventions
Deep or diaphragmatic breathing is taught prior to relaxation.
Tensing and releasing muscle groups in a specified order to help reduce tension and anxiety.
Eligibility Criteria
You may qualify if:
- Participants have a diagnosis of an anxiety disorder, specifically, Generalized Anxiety Disorder, Panic Disorder, Agoraphobia, Social Anxiety Disorder or Anxiety Disorder Unspecified/Other Specified).
- Participants speak English.
You may not qualify if:
- Diagnosis of Dementia
- Probable presence of significant cognitive impairment according to a brief cognitive screen
- Serious mental illness (schizophrenia, psychosis, bipolar disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Palo Alto Veterans Institute for Researchlead
- VA Palo Alto Health Care Systemcollaborator
- Brain & Behavior Research Foundationcollaborator
Study Sites (1)
VA Palo Alto Health Care System
Palo Alto, California, 94089, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Christine Gould, PhD
- Organization
- VA Palo Alto Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Christine E Gould, PhD
VA Palo Alto/Stanford University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor (affiliated)
Study Record Dates
First Submitted
April 21, 2015
First Posted
April 29, 2015
Study Start
May 1, 2015
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
January 27, 2020
Results First Posted
January 27, 2020
Record last verified: 2020-01